Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 812

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 812
---
 Offering, 1,212,122Preferred Shares with a conversion price of $ 1.65per share, for aggregate gross proceeds of $ 2million. Pursuant to the terms of the March 2025 SPA, the investors may purchase up to $ 1million of additional Preferred Shares on identical terms as the initial closing, subject to the Company obtaining shareholder approval. The March 2025 Offering closed on March 28, 2025. The initial closing of the March 2025 Offering resulted in gross proceeds to the Company of to $ 2million. The Company intends to use the net proceeds from the March 2025 Offering for working capital and general corporate purposes, including for expenses relating to the Merger. Further, on March 31, 2025, the Company entered into a Common Shares Purchase Agreement with Alpha Capital Anstalt, or the Facility SPA, relating to a committed equity facility. Pursuant to the Facility SPA, the Company has the right from time to time at its option to sell to Alpha up to $ 25.0million of Company Common Shares, subject to certain conditions and limitations set forth in the Facility SPA. The purchase price of the Company Common Shares that the Company elects to sell to Alpha pursuant to the Facility SPA will be 95% of the volume weighted average price of the Company Common Shares during the applicable purchase date on which the Company has timely delivered written notice to Alpha directing it to purchase Company Common Shares under the Facility SPA. In connection with the execution of the Facility SPA, the Company agreed to issue a pre -fundedwarrant, or the Pre -FundedWarrant, to purchase $ 250,000in Company Common Shares to Alpha as consideration for its irrevocable commitment to purchase the Company Common Shares upon the terms and subject to the satisfaction of the conditions set forth in the Facility SPA. Annex F-28

Annex G Kadimastem Ltd. Financial Statements as of December 31, 2024 Table of Contents

|                                                                         |     | Annex G 
 Page    |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 1281) |     | G-2     |
| Statements of Financial Position                                        |     | G-3     |
| Statements of Profit or Loss and Other Comprehensive Loss               |     | G-4     |
| Statements of Changes in Equity                                         |     | G-5     |
| Statements of Cash Flows                                                |     | G-7     |
| Notes to the